A Study of Zasocitinib in Adults With Hidradenitis Suppurativa

ClinicalTrials.gov ID: NCT07244263

Public ClinicalTrials.gov record NCT07244263. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Jul 21, 2026, 6:41 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Assess Efficacy and Safety of Zasocitinib in Moderate to Severe Hidradenitis Suppurativa

Study identification

NCT ID: NCT07244263
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 2
Lead sponsor: Takeda; Industry
Enrollment: 90 participants

Conditions and interventions

Conditions

Hidradenitis Suppurativa

Interventions

Zasocitinib (Dose A) Drug
Placebo Other

Drug · Other

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Jan 25, 2026
Primary completion: Feb 21, 2028
Completion: Feb 21, 2028
Last update posted: Mar 5, 2026

2026 – 2028

United States locations

U.S. sites: 15
U.S. states: 11
U.S. cities: 15

Facility	City	State	ZIP	Site status
Mayo Clinic	Scottsdale	Arizona	85259	Not yet recruiting
Johnson Dermatology	Fort Smith	Arkansas	72916	Recruiting
First OC Dermatology Research	Fountain Valley	California	92708	Recruiting
Direct Helpers Research Center	Hialeah	Florida	33012	Not yet recruiting
Advanced Clinical Research Institute	Tampa	Florida	33607	Recruiting
Beth Israel Deaconess Medical Center	Boston	Massachusetts	02215	Not yet recruiting
Wayne State University	Detroit	Michigan	48201	Not yet recruiting
Hamzavi Dermatology	Fort Gratiot	Michigan	48059	Recruiting
StracSkin, PLLC	Greenland	New Hampshire	03840	Recruiting
Northwell Health Physician Partners	Lake Success	New York	11020	Not yet recruiting
Mount Sinai Doctors	New York	New York	10028	Not yet recruiting
Apex Clinical Research Center, LLC.	Mayfield Heights	Ohio	44124	Not yet recruiting
ODRC Enterprises, LLC dba Oregon Dermatology and Research Center	Portland	Oregon	97210	Not yet recruiting
Arlington Research Center, Inc.	Arlington	Texas	76011	Not yet recruiting
Texas Dermatology Research Center	Dallas	Texas	75246	Not yet recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 34 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT07244263, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Mar 5, 2026 · Synced Jul 21, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07244263 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →